insights_auto
Outlook: 65.2% bullish·0.0% bearish
Go to analysischevron_right
RHHBY:OTCMKTS
Roche Holdings AG Basel ADR Common Stock
US$53,83
arrow_downward
-0,50%(-0,27) 1D
13 ຕ.ລ., 15 ໂມງ 26 ນາທີ 11 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHBY...
Open
US$54,55
High
US$54,57
Low
US$53,71
Mkt. cap
350,38 ຕື້
Avg. vol.
1,75 ລ້ານ
Volume
807,12 ພັນ
P/E ratio
23,45
52-wk high
US$60,85
52-wk low
US$40,07
EPS
US$2,30
Beta
0,42
Shares outstanding
5,62 ຕື້
No. of employees
113 ພັນ
Open
US$54,55
High
US$54,57
Low
US$53,71
Mkt. cap
350,38 ຕື້
Avg. vol.
1,75 ລ້ານ
Volume
807,12 ພັນ
P/E ratio
23,45
52-wk high
US$60,85
52-wk low
US$40,07
EPS
US$2,30
Beta
0,42
Shares outstanding
5,62 ຕື້
No. of employees
113 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
3 ຊົ່ວໂມງກ່ອນ
Roche extends China deal streak with $1B pact for RNAi obesity drug
Reuters
·
5 ຊົ່ວໂມງກ່ອນ
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
5 ຊົ່ວໂມງກ່ອນ
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
·
7 ຊົ່ວໂມງກ່ອນ
Roche Holding stock rises 3.44 percent on SIX
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holdings AG Basel ADR Common Stock
CEOThomas Schinecker
Employees113 ພັນ
Founded1 ຕ.ລ. 1896
Headquartersບາເຊວ, Basel City, ສະວິດເຊີແລນ
SectorPharmaceutical industry
Websiteroche.com